Recent News

• 08.05.2026 - Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights
• 07.22.2026 - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 07.22.2026 - Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026
• 07.14.2026 - Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 07.13.2026 - Geron Announces Appointment of Chinmaya Rath as Chief Business Officer
• 06.18.2026 - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 06.01.2026 - Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
• 05.18.2026 - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 05.12.2026 - First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026
• 05.06.2026 - Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights

Recent Filings

• 08.05.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 08.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2026 - 8-K Current report
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors